Percussionaire’s TRUE-IPV® products are trusted by medical professionals around the world for a broad range of clinical conditions. All of our devices are built to be durable and versatile, feature our patented Phasitron® Technology, and include extensive service and support for patients and providers.
The Impulsator®
The original Impulsator® is designed for functional durability for use in a home care environment.
Benefits:
- Restores FRC
- May reduce hospital re-admissions
- Improves Oxygenation and reduces PaCO2
- May reduce COPD exacerbations
- May reduce pulmonary infection (pneumonia, influenza)
- Improves airway clearance
- Lung expansion through gentle recruitment
The IPV®-1C
The IPV®-1C is designed specifically for
non-continuous institutional/hospital use.
The IPV®-1C is a high-frequency, flow-regulated,
time-cycled ventilator that provides TRUE-IPV®
therapy, a modality of mechanical ventilation,
“Intrapulmonary Percussive Ventilation” (IPV®).
Benefits:
- Restores FRC
- Reduces time in the ICU
- Improves Oxygenation and reduces PaCO2
- Provides better management of COPD exacerbations
- Reduces nosocomial infection
- Improves airway clearance
- Lung recruitment by treating atelectasis
The IPV®-2C
The IPV®-2C enhances the clinical versatility of TRUE-IPV® therapy having a selectable percussive amplitude and frequency for the mobilization and airway clearance of retained endobronchial secretions and the resolution of diffuse patchy atelectasis during mechanical airway recruitment.
Benefits:
- Restores FRC
- Reduces time in the ICU
- Reduces oxygen need at discharge from NICU
- Improves Oxygenation and reduces PaCO2
- Provides better management of COPD exacerbations
- Reduces nosocomial infection
- Improves airway clearance
- Lung recruitment by treating atelectasis
- Demand CPAP
VDR®-4
The VDR®-4 s designed specifically for hospital use. The Volumetric Diffusive Respirator unit (VDR®-4) is a flow-regulated and time-cycled ventilator that provides high-frequency percussive ventilation (HFPV).
Benefits:
- Improves outcomes for patients on ECMO
- Ventilates patients failing other modes of ventilation
- Restores FRC and may reduce need for ECMO
- Assists with weaning from ECMO
- Improves Oxygenation and reduces PaCO2
- Improves airway clearance (such as meconium)
- May be used non-invasively, particularly in the NICU
